Cargando…

Evaluation of tau deposition using (18)F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study

BACKGROUND: The ability of (18)F-PI-2620 PET to measure the spatial distribution of tau pathology in Alzheimer’s disease (AD) has been demonstrated in previous studies. The objective of this work was to evaluate tau deposition using (18)F-PI-2620 PET in beta-amyloid positive subjects with a diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bullich, Santiago, Mueller, Andre, De Santi, Susan, Koglin, Norman, Krause, Stephen, Kaplow, June, Kanekiyo, Michio, Roé-Vellvé, Núria, Perrotin, Audrey, Jovalekic, Aleksandar, Scott, David, Gee, Michelle, Stephens, Andrew, Irizarry, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327167/ https://www.ncbi.nlm.nih.gov/pubmed/35897078 http://dx.doi.org/10.1186/s13195-022-01048-x

Ejemplares similares

Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD
por: Bryant, Annie G., et al.
Publicado: (2021)

Head injury is associated with tau deposition on PET in MCI and AD patients
por: Risacher, Shannon L., et al.
Publicado: (2021)

Multicenter (18)F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
por: Rullmann, Michael, et al.
Publicado: (2022)

Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau
por: Dickerson, Bradford C., et al.
Publicado: (2013)

Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for in vitro Assessment of Progressive Supranuclear Palsy Tau Pathology With [(18)F]PI-2620
por: Willroider, Marie, et al.
Publicado: (2021)

Feasibility of short imaging protocols for [(18)F]PI-2620 tau-PET in progressive supranuclear palsy
por: Song, Mengmeng, et al.
Publicado: (2021)

The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD
por: Fessel, Jeffrey
Publicado: (2020)

Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
por: Kroth, Heiko, et al.
Publicado: (2019)

Optimized classification of (18)F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment
por: Bullich, Santiago, et al.
Publicado: (2017)

The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer’s Disease (AD)
por: Mroczko, Barbara, et al.
Publicado: (2019)

AD genetic risk factors and tau spreading
por: Avila, Jesús, et al.
Publicado: (2015)

Advances and considerations in AD tau-targeted immunotherapy
por: Bittar, Alice, et al.
Publicado: (2019)

Early-phase [(18)F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury
por: Beyer, Leonie, et al.
Publicado: (2020)

Binding characteristics of [(18)F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET
por: Song, Mengmeng, et al.
Publicado: (2021)

Case Report: [(18)F]PI2620 as a Tau Imaging Agent in Posterior Cortical Atrophy
por: Kong, Yu, et al.
Publicado: (2020)

The AD tau core spontaneously self-assembles and recruits full-length tau to filaments
por: Carlomagno, Yari, et al.
Publicado: (2021)

Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
por: Mate De Gerando, Anastasie, et al.
Publicado: (2023)

A Novel Deep Learning Radiomics Model to Discriminate AD, MCI and NC: An Exploratory Study Based on Tau PET Scans from ADNI †
por: Zhao, Yan, et al.
Publicado: (2022)

Quantitative Assessment of Hippocampal Tau Pathology in AD and PART
por: Zhang, Lei, et al.
Publicado: (2020)

Axonal Degeneration in AD: The Contribution of Aβ and Tau
por: Salvadores, Natalia, et al.
Publicado: (2020)

AD-NET: Age-adjust neural network for improved MCI to AD conversion prediction
por: Gao, Fei, et al.
Publicado: (2020)

New protein deposition tracers in the pipeline
por: Jovalekic, Aleksandar, et al.
Publicado: (2016)

Host Tau Genotype Specifically Designs and Regulates Tau Seeding and Spreading and Host Tau Transformation Following Intrahippocampal Injection of Identical Tau AD Inoculum
por: Andrés-Benito, Pol, et al.
Publicado: (2022)

Early detection of amyloid load using (18)F-florbetaben PET
por: Bullich, Santiago, et al.
Publicado: (2021)

Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods
por: Jovalekic, Aleksandar, et al.
Publicado: (2023)

Evaluation of [(18)F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies
por: Tezuka, Toshiki, et al.
Publicado: (2021)

Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [(18)F]-PI-2620 tau-PET signal
por: Schönecker, Sonja, et al.
Publicado: (2023)

An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients
por: Aksu, Yaman, et al.
Publicado: (2011)

Findings of (18)F‐PI‐2620 tau PET imaging in patients with Alzheimer’s disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample
por: Bun, Shogyoku, et al.
Publicado: (2022)

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
por: Gibbons, Garrett S., et al.
Publicado: (2019)

CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD
por: Ermann, Natalia, et al.
Publicado: (2018)

Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
por: Bertens, Daniela, et al.
Publicado: (2019)

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice
por: Dai, Chun-ling, et al.
Publicado: (2018)

Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults
por: Yu, Lei, et al.
Publicado: (2023)

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
por: Shen, Li, et al.
Publicado: (2013)

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)
por: Bauckneht, Matteo, et al.
Publicado: (2018)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway
por: Pak, Victoria M., et al.
Publicado: (2020)

Brain signatures based on structural MRI: Classification for MCI, PMCI, and AD
por: Gonuguntla, Venkateswarlu, et al.
Publicado: (2022)

Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice
por: Stojakovic, Andrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qv628na2eq4sm7ifqebpiuv0eh